Advances in the Treatment of Childhood Acute Lymphoblastic Leukemia
In recent decades, survival rates for childhood acute lymphoblastic leukemia have improved remarkably, as demonstrated by risk-stratified, prospective multicenter studies. Treatment protocols have evolved and become better matched to both prognostic factors and treatment responses. Recently, new mol...
Main Author: | Hyery Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Society of Pediatric Hematology-Oncology
2019-04-01
|
Series: | Clinical Pediatric Hematology-Oncology |
Subjects: | |
Online Access: | https://doi.org/10.15264/cpho.2019.26.1.12 |
Similar Items
-
Treatment of childhood acute lymphoblastic leukemia in Jakarta: Result of modified Indonesian National Protocol 94
by: Djajadiman Gatot, et al.
Published: (2016-10-01) -
The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia
by: Elda Pereira Noronha, et al.
Published: (2019-04-01) -
Corrigendum: The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia
by: Elda Pereira Noronha, et al.
Published: (2021-02-01) -
Survival and prognostic factors of childhood acute lymphoblastic leukemia
by: Emelyana Permatasari, et al.
Published: (2009-12-01) -
DNA methylation analysis in childhood acute lymphoblastic leukemia.
Published: (2007)